At the Inv€$tival Showcase our own Jane Theaker, CEO of PBD Biotech, will be pitching Actiphage TB, a rapid, phage-based diagnostic for tuberculosis disease progression.
Tuberculosis is the world’s most fatal infectious disease, and it can lay dormant in an infected individual until their immune system is compromised by another infection, stress or malnutrition.
The Actiphage TB test is able to detect the pathogen Mycobacterium tuberculosis in a blood sample when it escapes the body’s immune system, offering potential for a biomarker of disease progression. This utility could be used both in targeting ‘test and treat’ campaigns and also in improving drug development by providing a ‘test of cure.’
Rapid diagnostics is a huge growth area in the aftermath of Covid as the community now appreciates the importance of rapid detection and treatment in the management of pandemics.
More about Inv€$tival Showcase: https://www.lsxleaders.com/investival-showcase
